Third-party apps often sit outside the same governance, monitoring, and contractual controls as internal systems, yet they may still receive access to sensitive data through shared APIs. That creates a gap between who can see the data, who is accountable for it, and who can revoke access when the relationship changes.
Why Third-Party Health Apps Raise the Stakes
Third-party health apps usually reach sensitive data through shared APIs, delegated tokens, and vendor relationships that sit outside the organisation’s day-to-day controls. That matters because the privacy risk is not only about data exposure, but also about consent scope, downstream reuse, and weak revocation when access is no longer needed. NHI Management Group research on third-party OAuth visibility shows 85% of organisations lack full visibility into external vendors connected through OAuth apps, which makes app sprawl a governance problem as much as a technical one.
Internal systems are typically covered by tighter asset inventories, security monitoring, and change control. By contrast, third-party apps often introduce separate operators, weaker logging, and different retention practices, so the organisation may not know where data flows after it leaves the core environment. Guidance from the OWASP Non-Human Identity Top 10 aligns with what The State of Non-Human Identity Security highlights: the most dangerous gap is often not access itself, but poor visibility into which apps still hold it.
In practice, many security teams discover risky app access only after a vendor relationship has changed or a token has already been abused, rather than through intentional review.
How the Risk Actually Shows Up in Practice
Third-party health apps tend to create risk in three layers. First, the app becomes a non-human identity with its own tokens, service accounts, or OAuth grants. Second, the app may be given access that is broader than the minimum needed because product teams optimise for integration speed. Third, the data lifecycle extends beyond the organisation’s perimeter, so the app can cache, export, or process patient-related data in ways that are hard to inspect later.
The practical question is not whether the app is “trusted,” but whether its access is continuously governed. Current best practice is to treat external apps as ephemeral and context-bound wherever possible: short-lived tokens, explicit scopes, frequent reauthorization, and automated revocation when the app is removed or dormant. That approach fits the direction of the NIST Cybersecurity Framework 2.0, which emphasises governance, access control, and continuous risk management, and it is consistent with NHIMG guidance in the Ultimate Guide to NHIs — Key Challenges and Risks.
- Inventory every external app, its owner, and its data scopes.
- Map OAuth grants, API keys, and service accounts to a business purpose.
- Set expiration and review dates for all third-party access.
- Log token issuance, API use, and revocation events centrally.
- Require security review before expanding scopes or adding new data types.
This guidance tends to break down when apps are integrated through shadow IT or when clinical workflows depend on unmanaged vendor connections that bypass central approval.
Where the Standard Answer Breaks Down
Tighter third-party controls often increase friction for users and product teams, so organisations have to balance privacy protection against integration speed and operational continuity. That tradeoff becomes more visible in health environments where clinicians need fast access, but patient data also demands strict containment.
There is no universal standard for this yet, but current guidance suggests a risk-based tiering model: apps handling patient records, messaging, or billing data should face stronger approval, shorter token lifetimes, and more frequent access review than low-risk productivity tools. It is also important to distinguish vendor-managed access from internal access, because the same permission set can carry very different exposure once data crosses organisational boundaries. The 52 NHI Breaches Analysis shows how often failures involve credentials, secrets, and third-party trust paths rather than a direct compromise of the core system.
Health apps are especially risky when they combine broad patient-data scopes with weak transparency on subprocessors, analytics, or mobile SDKs. Those controls tend to break down when a vendor can persist access through long-lived tokens and opaque downstream processing, because revocation and auditability become unreliable.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Non-Human Identity Top 10 address the attack and risk surface, while NIST CSF 2.0 and NIST AI RMF set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| OWASP Non-Human Identity Top 10 | NHI-01 | Third-party app tokens and grants are non-human identities needing strict inventory and governance. |
| NIST CSF 2.0 | PR.AC-1 | External app access must be governed and limited to authorized users and services. |
| NIST AI RMF | Health apps using AI or automation need risk governance across data flow and accountability. |
Catalog every external app, scope, owner, and token so access can be reviewed and revoked quickly.
